As the uncertainty around the regulatory status of NAC (N-acetyl cysteine) continues, it is important the industry doesn’t lose this for the precedent it sets for other potential ingredients, said CRN’s Steve Mister.
The US Food and Drug Administration has announced that Dr Cara Welch will be the new permanent director of its Office of Dietary Supplement Programs. The announcement was welcomed by industry trade groups.
